+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

APAC Clinical Diagnostics Market 2021-2031

  • PDF Icon

    Report

  • 114 Pages
  • February 2022
  • Region: Asia Pacific
  • GMD Research
  • ID: 5552829
Asia Pacific clinical diagnostics market will grow by 9.8% annually with a total addressable market cap of $257.46 billion over 2022-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer.



Highlighted with 30 tables and 59 figures, this 114-page report “Asia Pacific Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Country.

Based on Test, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Lipid Panel
  • Infectious Disease Testing
  • Liver Panel
  • Complete Blood Count (CBC)
  • Electrolyte Testing
  • Renal Panel
  • Other Tests

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Instruments
  • Assay Kits & Reagents
  • Software & Services

By Indication the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Cardiovascular
  • Cancer
  • Infectious Disease
  • Stroke
  • Chronic Lower Respiratory Diseases
  • Diabetes
  • Other Indications

By Patient Gender the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Male Patients
  • Female Patients

By Age Group the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Age 44 and below
  • Age 45-64
  • Age 65 and over

By End User the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Hospital & Clinics Laboratory
  • Diagnostic Laboratory
  • Point-of-Care Testing
  • Other End Users

Geographically, the following national/local markets are fully investigated:

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Test, Product, and Indication, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • BioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Bio-Reference Laboratories
  • Bioscientia Healthcare
  • Charles River Laboratories
  • Danaher Corporation
  • Hoffmann-La Roche AG
  • Hologic Inc.
  • Qiagen NV
  • Siemens Healthcare
  • Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions about the APAC Clinical Diagnostics Market

What is the estimated value of the APAC Clinical Diagnostics Market?

The APAC Clinical Diagnostics Market was estimated to be valued at $14785.3 Million in 2021.

What is the growth rate of the APAC Clinical Diagnostics Market?

The growth rate of the APAC Clinical Diagnostics Market is 9.8%, with an estimated value of $37664.2 Million by 2031.

What is the forecasted size of the APAC Clinical Diagnostics Market?

The APAC Clinical Diagnostics Market is estimated to be worth $37664.2 Million by 2031.

Who are the key companies in the APAC Clinical Diagnostics Market?

Key companies in the APAC Clinical Diagnostics Market include Selected Key Players:, • Abbott Laboratories, • Becton, Dickinson and Company, • BioMerieux SA, • Bio, Rad Laboratories Inc., • Bio, Reference Laboratories and • Charles River Laboratories.

Table of Contents

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis
3 Segmentation of Asia Pacific Market by Test
3.1 Market Overview by Test
3.2 Lipid Panel
3.3 Infectious Disease Testing
3.4 Liver Panel
3.5 Complete Blood Count (CBC)
3.6 Electrolyte Testing
3.7 Renal Panel
3.8 Other Tests
4 Segmentation of Asia Pacific Market by Product
4.1 Market Overview by Product
4.2 Instruments
4.3 Assay Kits & Reagents
4.4 Software & Services
5 Segmentation of Asia Pacific Market by Indication
5.1 Market Overview by Indication
5.2 Cardiovascular
5.3 Cancer
5.4 Infectious Disease
5.5 Stroke
5.6 Chronic Lower Respiratory Diseases
5.7 Diabetes
5.8 Other Indications
6 Segmentation of Asia Pacific Market by Patient Gender
6.1 Market Overview by Patient Gender
6.2 Male Patients
6.3 Female Patients
7 Segmentation of Asia Pacific Market by Age Group
7.1 Market Overview by Age Group
7.2 Age 44 and below
7.3 Age 45-64
7.4 Age 65 and over
8 Segmentation of Asia Pacific Market by End User
8.1 Market Overview by End User
8.2 Hospital & Clinics Laboratory
8.3 Diagnostic Laboratory
8.4 Point-of-Care Testing
8.5 Other End Users
9 Asia-Pacific Market 2021-2031 by Country
9.1 Overview of Asia-Pacific Market
9.2 Japan
9.3 China
9.4 Australia
9.5 India
9.6 South Korea
9.7 Rest of APAC Region
10 Competitive Landscape
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • BioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Bio-Reference Laboratories
  • Bioscientia Healthcare
  • Charles River Laboratories
  • Danaher Corporation
  • Hoffmann-La Roche AG
  • Hologic Inc.
  • Qiagen NV
  • Siemens Healthcare
  • Thermo Fisher Scientific

List of Tables:

Table 1. Snapshot of Asia Pacific Clinical Diagnostics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Health Spending by Region, $ bn, 2013-2020
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Clinical Diagnostics Market
Table 5. Asia Pacific Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 6. Asia Pacific Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 7. Asia Pacific Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 8. Asia Pacific Clinical Diagnostics Market by Patient Gender, 2021-2031, $ mn
Table 9. Asia Pacific Clinical Diagnostics Market by Age Group, 2021-2031, $ mn
Table 10. Asia Pacific Clinical Diagnostics Market by End User, 2021-2031, $ mn
Table 11. APAC Clinical Diagnostics Market by Country, 2021-2031, $ mn
Table 12. Japan Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 13. Japan Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 14. Japan Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 15. China Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 16. China Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 17. China Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 18. Australia Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 19. Australia Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 20. Australia Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 21. India Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 22. India Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 23. India Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 24. South Korea Clinical Diagnostics Market by Test, 2021-2031, $ mn
Table 25. South Korea Clinical Diagnostics Market by Product, 2021-2031, $ mn
Table 26. South Korea Clinical Diagnostics Market by Indication, 2021-2031, $ mn
Table 27. Clinical Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 28. Abbott Laboratories: Company Snapshot
Table 29. Abbott Laboratories: Business Segmentation
Table 30. Abbott Laboratories: Product Portfolio

List of Figures:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Asia Pacific Clinical Diagnostics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Clinical Diagnostics Market
Figure 7. Leading Causes of Death in the World, 2019-2020, million
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Clinical Diagnostics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Five Forces Analysis of Asia Pacific Clinical Diagnostics Market
Figure 13. Breakdown of Asia Pacific Clinical Diagnostics Market by Test, 2021-2031, % of Revenue
Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Test, Value ($ mn) and Share (%)
Figure 15. Asia Pacific Clinical Diagnostics Market by Test: Lipid Panel, 2021-2031, $ mn
Figure 16. Asia Pacific Clinical Diagnostics Market by Test: Infectious Disease Testing, 2021-2031, $ mn
Figure 17. Asia Pacific Clinical Diagnostics Market by Test: Liver Panel, 2021-2031, $ mn
Figure 18. Asia Pacific Clinical Diagnostics Market by Test: Complete Blood Count (CBC), 2021-2031, $ mn
Figure 19. Asia Pacific Clinical Diagnostics Market by Test: Electrolyte Testing, 2021-2031, $ mn
Figure 20. Asia Pacific Clinical Diagnostics Market by Test: Renal Panel, 2021-2031, $ mn
Figure 21. Asia Pacific Clinical Diagnostics Market by Test: Other Tests, 2021-2031, $ mn
Figure 22. Breakdown of Asia Pacific Clinical Diagnostics Market by Product, 2021-2031, % of Sales Revenue
Figure 23. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)
Figure 24. Asia Pacific Clinical Diagnostics Market by Product: Instruments, 2021-2031, $ mn
Figure 25. Asia Pacific Clinical Diagnostics Market by Product: Assay Kits & Reagents, 2021-2031, $ mn
Figure 26. Asia Pacific Clinical Diagnostics Market by Product: Software & Services, 2021-2031, $ mn
Figure 27. Breakdown of Asia Pacific Clinical Diagnostics Market by Indication, 2021-2031, % of Sales Revenue
Figure 28. Asia Pacific Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%)
Figure 29. Asia Pacific Clinical Diagnostics Market by Indication: Cardiovascular, 2021-2031, $ mn
Figure 30. Asia Pacific Clinical Diagnostics Market by Indication: Cancer, 2021-2031, $ mn
Figure 31. Asia Pacific Clinical Diagnostics Market by Indication: Infectious Disease, 2021-2031, $ mn
Figure 32. Asia Pacific Clinical Diagnostics Market by Indication: Stroke, 2021-2031, $ mn
Figure 33. Asia Pacific Clinical Diagnostics Market by Indication: Chronic Lower Respiratory Diseases, 2021-2031, $ mn
Figure 34. Asia Pacific Clinical Diagnostics Market by Indication: Diabetes, 2021-2031, $ mn
Figure 35. Asia Pacific Clinical Diagnostics Market by Indication: Other Indications, 2021-2031, $ mn
Figure 36. Breakdown of Asia Pacific Clinical Diagnostics Market by Patient Gender, 2021-2031, % of Revenue
Figure 37. Asia Pacific Addressable Market Cap in 2022-2031 by Patient Gender, Value ($ mn) and Share (%)
Figure 38. Asia Pacific Clinical Diagnostics Market by Patient Gender: Male Patients, 2021-2031, $ mn
Figure 39. Asia Pacific Clinical Diagnostics Market by Patient Gender: Female Patients, 2021-2031, $ mn
Figure 40. Breakdown of Asia Pacific Clinical Diagnostics Market by Age Group, 2021-2031, % of Revenue
Figure 41. Asia Pacific Addressable Market Cap in 2022-2031 by Age Group, Value ($ mn) and Share (%)
Figure 42. Asia Pacific Clinical Diagnostics Market by Age Group: Age 44 and below, 2021-2031, $ mn
Figure 43. Asia Pacific Clinical Diagnostics Market by Age Group: Age 45-64, 2021-2031, $ mn
Figure 44. Asia Pacific Clinical Diagnostics Market by Age Group: Age 65 and over, 2021-2031, $ mn
Figure 45. Breakdown of Asia Pacific Clinical Diagnostics Market by End User, 2021-2031, % of Revenue
Figure 46. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 47. Asia Pacific Clinical Diagnostics Market by End User: Hospital & Clinics Laboratory, 2021-2031, $ mn
Figure 48. Asia Pacific Clinical Diagnostics Market by End User: Diagnostic Laboratory, 2021-2031, $ mn
Figure 49. Asia Pacific Clinical Diagnostics Market by End User: Point-of-Care Testing, 2021-2031, $ mn
Figure 50. Asia Pacific Clinical Diagnostics Market by End User: Other End Users, 2021-2031, $ mn
Figure 51. Breakdown of APAC Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 52. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 53. Clinical Diagnostics Market in Japan, 2021-2031, $ mn
Figure 54. Clinical Diagnostics Market in China, 2021-2031, $ mn
Figure 55. Clinical Diagnostics Market in Australia, 2021-2031, $ mn
Figure 56. Clinical Diagnostics Market in India, 2021-2031, $ mn
Figure 57. Clinical Diagnostics Market in South Korea, 2021-2031, $ mn
Figure 58. Clinical Diagnostics Market in Rest of APAC, 2021-2031, $ mn
Figure 59. Growth Stage of Asia Pacific Clinical Diagnostics Industry over the Forecast Period

Companies Mentioned

  • Selected Key Players:
  • • Abbott Laboratories
  • • Becton, Dickinson and Company
  • • BioMerieux SA
  • • Bio-Rad Laboratories Inc.
  • • Bio-Reference Laboratories
  • • Bioscientia Healthcare
  • • Charles River Laboratories
  • • Danaher Corporation
  • • Hoffmann-La Roche AG
  • • Hologic Inc.
  • • Qiagen NV
  • • Siemens Healthcare
  • • Thermo Fisher Scientific

Methodology

Loading
LOADING...